HCP (HCP) Given New $26.00 Price Target at Robert W. Baird

HCP (NYSE:HCP) had its price target reduced by Robert W. Baird from $29.00 to $26.00 in a note issued to investors on Friday, January 5th, Marketbeat Ratings reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. Robert W. Baird’s target price would suggest a potential upside of 9.98% from the company’s previous close.

Several other equities analysts also recently weighed in on the company. Zacks Investment Research downgraded HCP from a “hold” rating to a “sell” rating in a report on Tuesday, January 2nd. Bank of America downgraded HCP from a “buy” rating to a “neutral” rating and reduced their price target for the company from $33.00 to $31.00 in a report on Friday, September 22nd. Stifel Nicolaus upgraded HCP from a “hold” rating to a “buy” rating and set a $29.00 price target for the company in a report on Tuesday, December 5th. Mizuho upgraded HCP from a “neutral” rating to a “buy” rating and set a $32.00 price objective for the company in a report on Thursday, November 2nd. Finally, JPMorgan Chase & Co. upgraded HCP from a “neutral” rating to an “overweight” rating and set a $29.00 price objective for the company in a report on Friday, December 15th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $30.14.

HCP (HCP) opened at $23.64 on Friday. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 1.17. The company has a market capitalization of $11,089.72, a price-to-earnings ratio of 21.30, a price-to-earnings-growth ratio of 2.64 and a beta of 0.38. HCP has a 52-week low of $23.61 and a 52-week high of $33.67.

HCP (NYSE:HCP) last announced its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.48 EPS for the quarter, beating the consensus estimate of $0.46 by $0.02. The business had revenue of $454.00 million during the quarter, compared to analyst estimates of $440.60 million. HCP had a return on equity of 8.85% and a net margin of 27.31%. The company’s revenue for the quarter was down 14.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.72 earnings per share. equities research analysts forecast that HCP will post 1.94 EPS for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in HCP. Sun Life Financial INC lifted its position in shares of HCP by 42,675.0% during the 2nd quarter. Sun Life Financial INC now owns 3,422 shares of the real estate investment trust’s stock valued at $109,000 after buying an additional 3,414 shares in the last quarter. Advisory Services Network LLC lifted its position in shares of HCP by 4.1% during the 2nd quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock valued at $121,000 after buying an additional 150 shares in the last quarter. Fieldpoint Private Securities LLC purchased a new position in HCP in the 3rd quarter worth approximately $147,000. Penserra Capital Management LLC purchased a new position in HCP in the 3rd quarter worth approximately $163,000. Finally, Cetera Investment Advisers purchased a new position in HCP in the 2nd quarter worth approximately $208,000. Institutional investors and hedge funds own 90.07% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “HCP (HCP) Given New $26.00 Price Target at Robert W. Baird” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/16/hcp-hcp-price-target-lowered-to-26-00-at-robert-w-baird.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply